[HTML][HTML] Plasminogen activator inhibitor-1 (PAI-1) 4G/5G promoter polymorphisms and risk of venous thromboembolism–a meta-analysis and systematic review
Q Zhang, YR Jin, XM Li, XQ Peng, N Peng, JF Song… - Vasa, 2020 - econtent.hogrefe.com
Background: A 4G/5G polymorphism in the promoter region of the plasminogen activator
inhibitor type 1 (PAI-1) gene has been reported to enhance the plasma levels of PAI-1 …
inhibitor type 1 (PAI-1) gene has been reported to enhance the plasma levels of PAI-1 …
Risk of venous thromboembolism associated with single and combined effects of Factor V Leiden, Prothrombin 20210A and Methylenetethraydrofolate reductase …
B Simone, V De Stefano, E Leoncini, J Zacho… - European journal of …, 2013 - Springer
Genetic and environmental factors interact in determining the risk of venous
thromboembolism (VTE). The risk associated with the polymorphic variants G1691A of factor …
thromboembolism (VTE). The risk associated with the polymorphic variants G1691A of factor …
[HTML][HTML] Epidemiology of activated protein C resistance and factor v leiden mutation in the mediterranean region
MM Jadaon - Mediterranean journal of hematology and infectious …, 2011 - ncbi.nlm.nih.gov
Venous thromboembolic disorders (VTE) are serious disorders with high morbidity and
mortality rates. Many genetic and acquired risk factors were identified to cause VTE. The …
mortality rates. Many genetic and acquired risk factors were identified to cause VTE. The …
Association between the plasminogen activator inhibitor-1 4G/5G polymorphism and risk of venous thromboembolism: a meta-analysis
Introduction The plasminogen activator inhibitor-1 (PAI-1) 4G/5G polymorphism was
considered to be associated with risk of venous thromboembolism (VTE), while evidence …
considered to be associated with risk of venous thromboembolism (VTE), while evidence …
Genetic mutations in Turkish population with pulmonary embolism and deep venous thrombosis
E Kupeli, H Verdi, A Simsek, FB Atac… - Clinical and Applied …, 2011 - journals.sagepub.com
Venous thromboembolism (VTE) is a universal health hazard. Inherited and acquired risk
factors increase the risk of VTE. We evaluated the relationship between factor V (G1691A …
factors increase the risk of VTE. We evaluated the relationship between factor V (G1691A …
[HTML][HTML] Psoriatic inflammation-induced atypically located venous thromboembolism: A case of immuno-thrombosis
The immune and hemostatic systems share a common evolutionary origin, both defend
against threats to organisms, and inflammation can cause venous thromboembolism. We …
against threats to organisms, and inflammation can cause venous thromboembolism. We …
[HTML][HTML] Dual diverse dynamic reversible actions of Ankaferd on EPCR and PAI-1 inside vascular endothelial cells with and without LPS
OBJECTIVE: Ankaferd Blood Stopper (ABS) comprises a mixture of the plants Thymus
vulgaris, Glycyrrhiza glabra, Vitis vinifera, Alpinia officinarum ve Urtica dioica. ABS has been …
vulgaris, Glycyrrhiza glabra, Vitis vinifera, Alpinia officinarum ve Urtica dioica. ABS has been …
The role of factor V Leiden in adult patients with venous thromboembolism: a meta-analysis of published studies from Turkey
A Eroglu, D Sertkaya, N Akar - Clinical and Applied …, 2012 - journals.sagepub.com
Factor V Leiden (FVL) is the most common inherited risk factor for venous thromboembolism
(VTE). The frequency of FVL in patients with VTE has been reported from different parts of …
(VTE). The frequency of FVL in patients with VTE has been reported from different parts of …
Failure to lyse venous thrombi because of elevated plasminogen activator inhibitor 1 (PAI-1) and 4G polymorphism of its promotor genome (The PAI-1/4G syndrome)
MM Bern, N McCarthy - Clinical and Applied Thrombosis …, 2010 - journals.sagepub.com
Plasminogen activator Inhibitor 1 (PAI-1) inhibits plasminogen activators leading to
decreased fibrinolysis and increased risk of thromboembolic disease (TED). Shifts in PAI-1 …
decreased fibrinolysis and increased risk of thromboembolic disease (TED). Shifts in PAI-1 …
[PDF][PDF] BHMT polymorphism and susceptibility to PTE in Chinese patients
WH Zhang, SM Zhao, JF Guo, YP Liu… - Eur Rev Med …, 2023 - europeanreview.org
OBJECTIVE: Pulmonary thromboembolism (PTE) is as a common form of venous thrombosis
and a potentially fatal cardiovascular disorder, which has become a severe clinical problem …
and a potentially fatal cardiovascular disorder, which has become a severe clinical problem …